DONNA SCHWAIGER: Open Payments
NPI 1700498052 · SWEDESBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 18 payments from 7 companies in 2025. Trend: 2023 $295 · 2024 $146 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 3 | $53 |
| Galderma Laboratories, L.P. | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| ABBVIE INC. | 2 | $29 |
| Organon LLC | 4 | $29 |
| Amgen Inc. | 1 | $14 |
Products named: TALTZ, NEMLUVIO, DUPIXENT, COSENTYX, SKYRIZI, HADLIMA, LIBTAYO, Otezla.
Industry payments across NJ — which companies pay providers there.
